Global Cord Blood Banking Market is Anticipate to Reach at a CAGR of 5.5% during the forecast period – PharmiWeb.com

A new research report published by Fior Markets with the titleCord Blood Banking Market by Type of Bank (Public, Private), Services (Processing, Storage), Application (Cancer, Blood Disorders, Immuno-deficiency Disorders, Metabolic Disorders, Bone Marrow Failure Syndrome), End-User (Hospitals, Research Institutes, Specialty Clinics), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027. Theglobal cord blood banking marketis expected to grow from USD 16.88 billion in 2019 to USD 25.90 billion by 2027, at a CAGR of 5.5% during the forecast period 2020-2027. The North America region dominates the market and holds the largest share in the year 2019

Read more
Advances in the Treatment of Mantle Cell Lymphoma are Greatly Improving the Long-Term Outlook for Patients – Curetoday.com

When James Landon received a mantle cell lymphoma (MCL) diagnosis in 2017, he was told his disease was indolent, meaning it was slow growing and didnt need to be treated right away, especially since he was feeling fine. But that changed in 2019. Landon, 50, an attorney in Tucson, Arizona, started to feel tired all the time.

Read more
Bioprinted therapeutic offers novel solution for treating Type 1 Diabetes – Canada NewsWire

Current treatments for diabetes are costlywith diabetes-related healthcare costs in Canada expected to increase to over $16.9 billion by 2020.They carry costs for patients as well, frequently in the form of negative side effects. One conventional method of treating T1D is the daily administration of insulin to manage blood sugar levels.

Read more
Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 – The Daily Chronicle

Fort Collins, Colorado Reports Globe recently added the Stem Cell Therapy Market Research Report that provides a thorough investigation of the market scenario of the market size, share, demand, growth, trends, and forecast from 2020-2027. The report covers the impact analysis of the COVID-19 pandemic

Read more
FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome – BioSpace

Sept. 23, 2020 10:00 UTC CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc., a leading regenerative medicine company in late-stage clinical development, announced today that MultiStem cell therapy was granted Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for the acute respiratory distress syndrome (ARDS) program

Read more